According to Vaxart's latest financial reports the company's total assets are $91.83 M. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $91.83 M | -40.31% |
2022-12-31 | $0.15 B | -30.44% |
2021-12-31 | $0.22 B | 44.95% |
2020-12-31 | $0.15 B | 312.03% |
2019-12-31 | $37.03 M | 5.12% |
2018-12-31 | $35.22 M | |
2017-06-30 | $40.1 M | -44.84% |
2016-06-30 | $72.7 M | -8.44% |
2015-06-30 | $79.4 M | -30.35% |
2014-06-30 | $0.11 B | 32.87% |
2013-06-30 | $85.8 M | |
2011-12-31 | $97.96 M | -13.97% |
2010-12-31 | $0.11 B | -13.29% |
2009-12-31 | $0.13 B | -8.95% |
2008-12-31 | $0.14 B | -39.55% |
2007-12-31 | $0.23 B | -10.27% |
2006-12-31 | $0.26 B | -19.27% |
2005-12-31 | $0.32 B | -10.55% |
2004-12-31 | $0.36 B | -4.94% |
2003-12-31 | $0.38 B | 66.35% |
2002-12-31 | $0.23 B | -24.97% |
2001-12-31 | $0.31 B |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | $0.27 M | -99.70% | Bahamas |
NRC Health
NRC | $0.12 B | 33.33% | ๐บ๐ธ USA |